Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Tidbits from the Disclosure Statement

Such Quarterly Payment shall be comprised of

100% of TPL’s share of the distribution of MMP Portfolio proceeds from PDS

Good thing there is a second licensing firm cuz I don't see TPL spending much time licensing anything but Core and Fast..

Share
New Message
Please login to post a reply